For help on how to get the results you want, see our search tips.
4421 results
Medicine
Orphan designations Remove Orphan designations filter
Paediatric investigation plans Remove Paediatric investigation plans filter
Categories
Human Remove Human filter
-
List item
Orphan designation: (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-yl)pyrimidin-5-yl)ethan-1-amine for: Treatment of gastrointestinal stromal tumours
Date of first decision: 17/07/2017, Positive, Last updated: 22/05/2019 -
List item
Orphan designation: 2'-deoxyguanosylyl-(3',5'-phosphoryl)-2'-deoxythymidylyl-(3',5'-phosphoryl)- 2'-deoxyguanosylyl-(3',5'-phosphoryl)-2'-deoxycytidylyl-(3',5'-phosphoryl)-2'-deoxycytidylyl -(3',5'-phosphoryl)-2'-deoxycytidylyl-(3',5'-phosphoryl)-2'-deoxyguanosylyl... for: Treatment of diffuse large B-cell lymphoma
Date of first decision: 10/08/2015, Withdrawn, -
List item
Orphan designation: Sodium phenylbutyrate for: Treatment of ornithine-transcarbamylase deficiency
Date of first decision: 09/02/2012, Withdrawn, -
List item
Orphan designation: Masitinib mesilate for: Treatment of pancreatic cancer
Date of first decision: 28/10/2009, Positive, -
List item
Orphan designation: Glyceryl tri-(4-phenylbutyrate) for: Treatment of hyperargininaemia
Date of first decision: 10/06/2010, Positive, Last updated: 12/07/2019 -
List item
Orphan designation: Plitidepsin for: Treatment of post-essential thrombocythaemia myelofibrosis
Date of first decision: 23/02/2011, Withdrawn, -
List item
Orphan designation: Heterologous human adult liver-derived progenitor cells for: Treatment of argininosuccinic aciduria
Date of first decision: 17/07/2013, Positive, -
List item
Orphan designation: Olaratumab for: Treatment of soft tissue sarcoma
Date of first decision: 12/02/2015, Withdrawn, Last updated: 15/01/2020 -
List item
Orphan designation: Acetylcysteine for: Treatment of idiopathic pulmonary fibrosis
Date of first decision: 26/01/2005, Withdrawn, -
List item
Orphan designation: Recombinant protein derived from the saliva of the Ornithodoros moubata tick (nomacopan) for: Treatment of Guillain-Barré syndrome
Date of first decision: 27/06/2016, Positive, Last updated: 26/07/2016 -
List item
Orphan designation: Ursodeoxycholic acid for: Treatment of Niemann-Pick disease
Date of first decision: 22/05/2017, Positive, Last updated: 25/04/2019 -
List item
Orphan designation: Methylthioninium for: treatment of frontotemporal dementia with parkinsonism-17
Date of first decision: 26/11/2010, Positive, Last updated: 28/03/2019 -
List item
Orphan designation: Cladribine for: Treatment of indolent non-Hodgkin's lymphoma
Date of first decision: 18/09/2001, Expired, Last updated: 18/06/2014 -
List item
Orphan designation: humanised fusion protein consisting of extracellular domain of CD24 linked to IgG1 Fc domain for: Prevention of graft-versus-host disease
Date of first decision: 11/11/2015, Positive, Last updated: 09/11/2020 -
List item
Orphan designation: 5,6,7,8-Tetrahydrobiopterin for: Treatment of hyperphenylalaninaemia
Date of first decision: 02/10/2003, Positive, Last updated: 23/02/2007 -
List item
Orphan designation: Recombinant human serum amyloid P for: Prevention of scarring post glaucoma filtration surgery
Date of first decision: 09/10/2009, Withdrawn, -
List item
Orphan designation: 1, 1'-[1,4-Phenylenebis (methylene)]-bis-1,4,8,11-tetraazacyclotetradecane for: Treatment to mobilize progenitor cells prior to stem cell transplantation
Date of first decision: 20/10/2004, Positive, Last updated: 18/08/2008 -
List item
Orphan designation: Cyclo-Cys-Gly-Gln-Arg-Glu-Thr-Pro-Glu-Gly-Ala-Glu-Ala-Lys-Pro-Trp-Tyr-Cys for: Treatment of high-altitude pulmonary oedema
Date of first decision: 08/02/2013, Positive, -
List item
Orphan designation: 2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethylsulfamide for: Treatment of small cell lung cancer
Date of first decision: 22/08/2014, Positive, -
List item
Orphan designation: hydrocortisone for: Treatment of adrenal insufficiency
Date of first decision: 20/03/2007, Positive, Last updated: 20/10/2020 -
List item
Orphan designation: Autologous ex-vivo-expanded peripheral polyclonal lymphocytes enriched in activated natural killer cells for: Treatment of multiple myeloma
Date of first decision: 16/10/2017, Positive, -
List item
Orphan designation: Allogeneic ex-vivo-expanded umbilical-cord blood cells for: Treatment of acute myeloid leukaemia
Date of first decision: 27/02/2009, Withdrawn, -
List item
Orphan designation: Eflornithine for: Treatment of familial adenomatous polyposis (FAP)
Date of first decision: 20/09/2010, Positive, Last updated: 29/04/2019 -
List item
Orphan designation: Trientine tetrahydrochloride for: Treatment of Wilson's disease
Date of first decision: 19/03/2015, Withdrawn, -
List item
Orphan designation: Thalidomide for: Treatment of graft-versus-host disease
Date of first decision: 09/07/2001, Withdrawn, Last updated: 15/10/2009